Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Alnylam Pharmaceuticals, Inc.
Lobbying Relationship
Bills mentioned
H.R.5397: Joe Fiandra Access to Home Infusion Act of 2023
Sponsor: Brian Fitzpatrick (R-Pa.)
H.R.5539: Optimizing Research Progress Hope And New Cures Act
Sponsor: John Joyce (R-Pa.)
S.476: Maintaining Investments in New Innovation Act
Sponsor: Robert Menendez (D-N.J.)
H.R.5547: Maintaining Investments in New Innovation Act
Sponsor: Wiley Nickel (D-N.C.)
S.3131: ORPHAN Cures Act
Sponsor: John Barrasso (R-Wyo.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Deirdre Parsons | n/a |
| Chase Thomas | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate